Precigen (PGEN) Minority Interest (2013 - 2025)

Precigen (PGEN) reported Minority Interest of $30.9 million for Q2 2025, up 4.62% quarter-over-quarter from $29.5 million in Q1 2025.

Precigen (PGEN) Minority Interest (2013 - 2025) Analysis & Trends

Precigen (PGEN) has 9 years of Minority Interest data on file, last reported at $30.9 million in Q2 2025.

Minority Interest for Q2 2025 came in at $30.9 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was $30.9 million (changed N/A YoY), and the FY2024 annual result was $28.2 million, changed N/A from the prior year.
Minority Interest improved to $30.9 million in Q2 2025 per PGEN's latest filing, from $29.5 million in the prior quarter.
Over five years, Minority Interest peaked at $30.9 million in Q2 2025 and troughed at $28.2 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn
9	Abivax	95.45 Bn	95.45 Bn	-
10	Precigen	1.32 Bn	1.32 Bn	20.69 Mn

Download Data